eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2022, Volume 18, Issue 2 : 46-50
Research Article
Mechanical Thrombectomy in Acute STEMI Cases
 ,
 ,
 ,
1
Department of Cardiology, North-East Institute of Medical Sciences, Guwahati, Assam, India
2
Department of Cardiovascular Surgery, Guwahati Medical College & Hospital, Assam, India
3
Interventional Cardiology Research Unit, Royal Heart Centre, Kolkata, India
4
School of Biomedical Sciences, Manipal University, Karnataka, India
Received
Aug. 18, 2022
Revised
Sept. 29, 2022
Accepted
Nov. 11, 2022
Published
Dec. 21, 2022
Abstract

Acute ST-Elevation Myocardial Infarction (STEMI) remains a major cause of morbidity and mortality worldwide. While primary percutaneous coronary intervention (PCI) with stent implantation remains the gold standard, mechanical thrombectomy has emerged as an adjunctive method to improve thrombus burden removal, enhance coronary perfusion, and reduce microvascular obstruction. This study evaluates the efficacy, safety, and short-term outcomes of mechanical thrombectomy in acute STEMI patients presenting to a tertiary-level cardiac care hospital. A total of 182 patients were enrolled over an 18-month period and divided into two cohorts: PCI-only (n=92) and PCI + Mechanical Thrombectomy (n=90). Post-procedure TIMI flow grades, myocardial blush scores (MBS), left ventricular ejection fraction (LVEF), and 30-day major adverse cardiac events (MACE) rates were assessed. Results showed significant improvement in TIMI III flow (89.1% vs 73.2%), reduced thrombus burden, and lower incidence of no-reflow in the thrombectomy group. The findings suggest mechanical thrombectomy may provide added clinical benefits but requires careful case selection.

 

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Personalized Healthcare Using Genomic Data: Advancing Precision Medicine Through Genomic Innovation
51-55
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Community-Based Health Programs and Their Effectiveness: Evaluating Impacts on Population Health Outcomes
13-19
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.